scispace - formally typeset
A

Anna Collin

Researcher at Lund University

Publications -  30
Citations -  1098

Anna Collin is an academic researcher from Lund University. The author has contributed to research in topics: Induced pluripotent stem cell & Fluorescence in situ hybridization. The author has an hindex of 14, co-authored 27 publications receiving 858 citations.

Papers
More filters
Journal ArticleDOI

Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor

TL;DR: The hypothesis that the NAB2/STAT6 fusions will result in altered properties of the transcriptional co‐repressor NAB 2 ‐ a key regulator of the early growth response 1 (EGR1) transcription factor – was corroborated by global gene expression analysis; SFTs showed deregulated expression of EGR1 target genes, as well as of other, developmentally important genes.
Journal ArticleDOI

Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotype

TL;DR: Correlation with clinical features revealed that lipomas with rings/giant markers were larger, occurred in older patients, were more often deep‐seated, and seemed to have an increased tendency to recur locally, compared with tumors with other chromosome aberrations.
Journal ArticleDOI

Creation of a library of induced pluripotent stem cells from Parkinsonian patients

TL;DR: The generation of a comprehensive library of iPSC lines of familial PD and an associated synucleinopathy, multiple system atrophy is reported, which will be a valuable resource for identifying common and divergent mechanisms leading to neurodegeneration in PD and MSA.
Journal ArticleDOI

The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1

TL;DR: It is shown that a putative POU5F1P1 protein is localized in the nucleus, acts as a transcriptional activator and regulates the expression in a similar way to the POU4F1 isoform 1, but was a weaker activator than isoforms 1 and 2.